Page last updated: 2024-12-10

trans-10,cis-12-conjugated linoleic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

(10E,12Z)-octadecadienoic acid : An octadeca-10,12-dienoic acid having (10E,12Z)-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5282800
CHEMBL ID1093743
CHEBI ID44526
SCHEMBL ID14357949
SCHEMBL ID1810737
MeSH IDM0480578

Synonyms (51)

Synonym
ODD ,
10-trans-12-cis-conjugated linoleic acid
c18:2, n-6,8 cis,trans
10-trans-12-cis-linoleic acid
(e,z)-octadeca-10,12-dienoic acid
10,12-trans,cis-octadecanoic acid
10-trans-12-cis-cla
(10e,12z)-octadecadienoic acid
CHEBI:44526 ,
10-trans-12-cis-octadecadienoic acid
DB04746
(10e,12z)-octadeca-10,12-dienoic acid
trans-10, cis-12-octadecadienoic acid
10e,12z-octadecadienoic acid ,
LMFA01030125
t10c12 cla
2420-56-6
10e12z-cla
trans-10,cis-12 conjugated linoleic acid
trans-10, cis-12 conjugate linoleic acid
trans-10,cis-12-conjugated linoleic acid
CHEMBL1093743 ,
10,12-octadecadienoicacid, (10e,12z)- (9ci)
bdbm50394662
(10e,12z)-10,12-octadecadienoic acid
10-trans,12-cis-octadecadienoic acid
t10,c12-cla
trans-10-cis-12-octadecadienoic acid
N151ZM4M27 ,
10-trans,12-cis-linoleic acid
10,12-octadecadienoic acid, (z,e)-
unii-n151zm4m27
SCHEMBL14357949
SCHEMBL1810737
GKJZMAHZJGSBKD-NMMTYZSQSA-N
HMS3649F05
10(e),12(z)-octadecadienoic acid
DTXSID0040628
conjugated (10e,12z)-linoleic acid, analytical standard
trans,cis-octadeca-10,12-dienoic acid
(10e,12z)-10,12-octadecadienoate
10-trans-12-cis-octadecadienoate
10e,12z-octadecadienoate
10e, 12z-linoleic acid
Q419936
trans-10-cis-12-octadecadienoate
SR-01000946649-1
sr-01000946649
BRD-K26222048-001-01-7
trans-10,cis-12-conjugated-linoleic-acid
F71329

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" T10 and T11-CLA milk fats were well tolerated; no adverse effects or mortality were observed during the 2-week observation period."( Acute oral safety study of dairy fat rich in trans-10 C18:1 versus vaccenic plus conjugated linoleic acid in rats.
Anadón, A; Ares, I; De la Fuente, MA; Gómez-Cortés, P; Juárez, M; Martínez, MA; Martínez-Larrañaga, MR; Ramos, E, 2010
)
0.36

Compound-Compound Interactions

ExcerptReferenceRelevance
"The effect of dietary conjugated linoleic acid (CLA) supplementation in combination with fat from vegetable versus animal origin on the fatty acid deposition, including that of individual 18:1 and 18:2 (conjugated and non-conjugated) isomers, in the liver and muscle of obese rats was investigated."( Dietary CLA combined with palm oil or ovine fat differentially influences fatty acid deposition in tissues of obese Zucker rats.
Alfaia, CM; Alves, SP; Bessa, RJ; Castro, MF; Lopes, PA; Martins, SV; Prates, JA, 2012
)
0.38

Dosage Studied

ExcerptRelevanceReference
" The present study examined (1) the dose-response and time course characteristics of fatty acid-mediated ER stress and apoptosis in H4IIE liver cells; (2) whether saturated fatty acid-induced apoptosis involved the ER-associated caspase-12; and (3) whether trans-10, cis-12-conjugated linoleic acid, an inhibitor of stearoyl-CoA desaturase, influenced fatty acid-mediated ER stress and apoptosis."( Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells.
Pagliassotti, MJ; Wang, D; Wei, Y, 2007
)
0.34
" A dose-response effect was not observed."( Effects of trans-10,cis-12 conjugated linoleic acid on cholesterol metabolism in hypercholesterolaemic hamsters.
Fernández-Quintela, A; Macarulla, MT; Navarro, V; Portillo, MP; Rodríguez, VM; Simón, E, 2007
)
0.34
" Dose-response comparisons, however, suggest that the degree of reduction in milk fat synthesis is less in dairy goats compared with dairy cows and dairy sheep."( A conjugated linoleic acid supplement containing trans-10, cis-12 conjugated linoleic acid reduces milk fat synthesis in lactating goats.
Bauman, DE; de Veth, MJ; Gipson, TA; Lock, AL; Rovai, M, 2008
)
0.35
" After 2 days on the experimental diets, lactating dams were orally dosed with either water (control) or trans-10, cis-12 CLA (20 mg/day) for 5 days."( Dietary Fat Does Not Overcome trans-10, cis-12 Conjugated Linoleic Acid Inhibition of Milk Fat Synthesis in Lactating mice.
Bauman, DE; Boisclair, YR; Harvatine, KJ; Robblee, MM, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
octadeca-10,12-dienoic acidA conjugated linoleic acid having double bonds at positions 10 and 12.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Octadecanoid formation from linoleic acid028

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Fatty acid synthaseHomo sapiens (human)IC50 (µMol)100.00000.00772.46245.8000AID697051
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
osteoblast differentiationFatty acid synthaseHomo sapiens (human)
glandular epithelial cell developmentFatty acid synthaseHomo sapiens (human)
fatty acid metabolic processFatty acid synthaseHomo sapiens (human)
fatty acid biosynthetic processFatty acid synthaseHomo sapiens (human)
inflammatory responseFatty acid synthaseHomo sapiens (human)
ether lipid biosynthetic processFatty acid synthaseHomo sapiens (human)
neutrophil differentiationFatty acid synthaseHomo sapiens (human)
monocyte differentiationFatty acid synthaseHomo sapiens (human)
mammary gland developmentFatty acid synthaseHomo sapiens (human)
modulation by host of viral processFatty acid synthaseHomo sapiens (human)
cellular response to interleukin-4Fatty acid synthaseHomo sapiens (human)
establishment of endothelial intestinal barrierFatty acid synthaseHomo sapiens (human)
fatty-acyl-CoA biosynthetic processFatty acid synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
RNA bindingFatty acid synthaseHomo sapiens (human)
[acyl-carrier-protein] S-acetyltransferase activityFatty acid synthaseHomo sapiens (human)
[acyl-carrier-protein] S-malonyltransferase activityFatty acid synthaseHomo sapiens (human)
3-oxoacyl-[acyl-carrier-protein] synthase activityFatty acid synthaseHomo sapiens (human)
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activityFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
protein bindingFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
fatty acyl-[ACP] hydrolase activityFatty acid synthaseHomo sapiens (human)
phosphopantetheine bindingFatty acid synthaseHomo sapiens (human)
cadherin bindingFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxybutanoyl-[acyl-carrier-protein] hydratase activityFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
enoyl-[acyl-carrier-protein] reductase (NADPH) activityFatty acid synthaseHomo sapiens (human)
fatty acid synthase activityFatty acid synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
Golgi apparatusFatty acid synthaseHomo sapiens (human)
cytosolFatty acid synthaseHomo sapiens (human)
plasma membraneFatty acid synthaseHomo sapiens (human)
membraneFatty acid synthaseHomo sapiens (human)
melanosomeFatty acid synthaseHomo sapiens (human)
glycogen granuleFatty acid synthaseHomo sapiens (human)
extracellular exosomeFatty acid synthaseHomo sapiens (human)
cytoplasmFatty acid synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID464598Inhibition of CRM1 interaction with HIV1 HA-tagged Rev in HeLa cells assessed as inhibition of Rev nuclear export by indirect fluorescent antibody technique2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Unprecedented NES non-antagonistic inhibitor for nuclear export of Rev from Sida cordifolia.
AID697051Inhibition of FASN in human SKBR3 cells2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
The lipogenesis pathway as a cancer target.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (149)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's72 (48.32)29.6817
2010's75 (50.34)24.3611
2020's2 (1.34)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials13 (8.44%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other141 (91.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]